ABSTRACT
Systemic lupus erythematosus (lupus) is a global health problem where 20-80% patients display cognitive problems and central nervous system (CNS) dysfunction. Early diagnosis and treatment of lupus remains a clinical challenge. Exercise improves experimental lupus nephritis. However, the effects of exercise in CNS lupus remains unknown. This study investigates the effects of controlled exercise (CE) that consisted of treadmill walking (5 m/min for 10 min everyday) on experimental CNS lupus using the well-established mouse model, MRL/lpr mice. The MRL/lpr mice were subjected to CE from 8 weeks (preclinical) to 16 weeks (disease). Multiplex gene expression analysis revealed significant upregulation of genes involved in neurite growth, proliferation and synaptic plasticity, and a decrease in inflammatory genes including complement proteins, NFkB, chemokines and cytokines in exercised mice compared to the unmanipulated, age-matched controls. The loss of blood-brain barrier integrity, astrogliosis and edema seen in MRL/lpr mice were reduced with exercise. Exercised mice performed better in behavioral assessments such as open field, nesting, and tail suspension test. For the first time our results show that a supervised, well-regulated and controlled exercise regimen alleviates CNS lupus and could potentially serve as an intervention strategy to improve the quality of life. Exercise could also serve as an adjunct therapy for lupus and other neuroinflammatory diseases, thereby reducing the need for the current therapies with toxic side effects. The validity of the findings and a safe exercise regimen needs to be established by additional studies in patients.
Subject(s)
Exercise Therapy/methods , Lupus Vasculitis, Central Nervous System/therapy , Animals , Blood-Brain Barrier/metabolism , Brain/metabolism , Chemokines/metabolism , Cytokines/metabolism , Disease Models, Animal , Lupus Erythematosus, Systemic/physiopathology , Lupus Erythematosus, Systemic/therapy , Lupus Vasculitis, Central Nervous System/physiopathology , Male , Mice , Mice, Inbred MRL lpr , Neuroinflammatory Diseases , Physical Conditioning, Animal/methodsABSTRACT
A modified Carlson-Langer model for earthquakes is proposed, which includes nonlinear viscoelasticity. Several aftershocks are generated after the main shock owing to the damping of the additional viscoelastic force. Both the Gutenberg-Richter law and Omori's law are reproduced in a numerical simulation of the modified Carlson-Langer model on a critical percolation cluster of a square lattice.
ABSTRACT
The prognosis for brain metastasis from primary esophageal or gastric cancer is often poor because of late detection and a lack of effective treatments. We encountered two cases of long-term survival after resection of brain metastasis that was detected >1 year after primary esophagogastric junction adenocarcinoma resection. Both patients underwent total gastrectomy, middle to lower esophagectomy, and Roux-en-Y reconstruction using the jejunum, and intrathoracic anastomosis was performed via right thoracotomy and laparotomy for primary tumor resection as well as brain metastasis resection followed by CyberKnife irradiation. They remained recurrence free-one remains alive after 6.5 years, while the other died of myocardial infarction 4 years after surgery. The present cases emphasize that long-term survival in patients with brain metastasis from gastric cancer can be expected after resection and stereotactic radiosurgery of brain metastasis detected >1 year after the resection of primary gastric adenocarcinoma.
Subject(s)
Adenocarcinoma/secondary , Adenocarcinoma/surgery , Brain Neoplasms/secondary , Brain Neoplasms/surgery , Esophageal Neoplasms/pathology , Esophagogastric Junction , Stomach Neoplasms/pathology , Aged , Disease-Free Survival , Esophageal Neoplasms/surgery , Humans , Male , Middle Aged , Stomach Neoplasms/surgery , Time FactorsSubject(s)
Ventricular Fibrillation/diagnosis , Ventricular Fibrillation/physiopathology , Adult , Arrhythmias, Cardiac/diagnosis , Arrhythmias, Cardiac/epidemiology , Arrhythmias, Cardiac/physiopathology , Female , Follow-Up Studies , Humans , Male , Middle Aged , Recurrence , Risk Factors , Ventricular Fibrillation/epidemiologyABSTRACT
BACKGROUND: Recently, we and others reported that early repolarization (J wave) is associated with idiopathic ventricular fibrillation. However, its clinical and genetic characteristics are unclear. METHODS AND RESULTS: This study included 50 patients (44 men; age, 45 ± 17 years) with idiopathic ventricular fibrillation associated with early repolarization, and 250 age- and sex-matched healthy controls. All of the patients had experienced arrhythmia events, and 8 (16%) had a family history of sudden death. Ventricular fibrillation was inducible by programmed electric stimulation in 15 of 29 patients (52%). The heart rate was slower and the PR interval and QRS duration were longer in patients with idiopathic ventricular fibrillation than in controls. We identified nonsynonymous variants in SCN5A (resulting in A226D, L846R, and R367H) in 3 unrelated patients. These variants occur at residues that are highly conserved across mammals. His-ventricular interval was prolonged in all of the patients carrying an SCN5A mutation. Sodium channel blocker challenge resulted in an augmentation of early repolarization or development of ventricular fibrillation in all of 3 patients, but none was diagnosed with Brugada syndrome. In heterologous expression studies, all of the mutant channels failed to generate any currents. Immunostaining revealed a trafficking defect in A226D channels and normal trafficking in R367H and L846R channels. CONCLUSIONS: We found reductions in heart rate and cardiac conduction and loss-of-function mutations in SCN5A in patients with idiopathic ventricular fibrillation associated with early repolarization. These findings support the hypothesis that decreased sodium current enhances ventricular fibrillation susceptibility.
Subject(s)
Electrocardiography , Mutation , Sodium Channels/genetics , Ventricular Fibrillation/diagnosis , Ventricular Fibrillation/genetics , Adult , Cardiac Pacing, Artificial , Case-Control Studies , Cell Line , Electrophysiologic Techniques, Cardiac , Female , Genetic Predisposition to Disease , Heart Conduction System/metabolism , Heart Conduction System/physiopathology , Heart Rate , Humans , Immunohistochemistry , Japan , Logistic Models , Male , Membrane Potentials , Middle Aged , NAV1.5 Voltage-Gated Sodium Channel , Odds Ratio , Patch-Clamp Techniques , Phenotype , Predictive Value of Tests , Protein Transport , Sodium/metabolism , Sodium Channel Blockers/pharmacology , Sodium Channels/drug effects , Sodium Channels/metabolism , Transfection , Ventricular Fibrillation/metabolism , Ventricular Fibrillation/physiopathologyABSTRACT
BACKGROUND: Short QT syndrome (SQTS) is characterized by an abnormally short QT interval and sudden death. Due to the limited number of cases, the characteristics of SQTS are not well understood. It has been reported recently that early repolarization is associated with idiopathic ventricular fibrillation and the QT interval is short in patients with early repolarization. OBJECTIVE: The purpose of this study was to study the association between early repolarization and arrhythmic events in SQTS. METHODS: The study consisted of three cohorts: SQTS cohort (N = 37), control cohort with short QT interval and no arrhythmic events (N = 44), and control cohort with normal QT interval (N = 185). ECG parameters were compared among the study cohorts. RESULTS: Heart rate, PR interval, and QRS duration were similar among the three study cohorts. Early repolarization was more common in the SQTS cohort (65%) than in the short QT control cohort (30%) and the normal QT control cohort (10%). Duration from T-wave peak to T-wave end was longer in the SQTS cohort than in the short QT control cohort, although QT and corrected QT intervals were similar. In the SQTS cohort, there were more males among patients with arrhythmic events than in those with a family history but without arrhythmic events. In multivariate models, early repolarization was associated with arrhythmic events in the SQTS cohort. ECG parameters including QT and QTc intervals were not associated with arrhythmic events in the SQTS cohort. CONCLUSION: There is a high prevalence of early repolarization in patients with SQTS. Early repolarization may be useful in identifying risk of cardiac events in SQTS.
Subject(s)
Ventricular Fibrillation/epidemiology , Adult , Arrhythmias, Cardiac/diagnosis , Arrhythmias, Cardiac/epidemiology , Arrhythmias, Cardiac/genetics , Case-Control Studies , Cohort Studies , Confidence Intervals , ERG1 Potassium Channel , Electrocardiography , Ether-A-Go-Go Potassium Channels/genetics , Female , Genetic Markers , Genetic Testing , Heart Rate , Humans , Japan/epidemiology , KCNQ1 Potassium Channel/genetics , Male , Middle Aged , Multivariate Analysis , Odds Ratio , Potassium Channels, Inwardly Rectifying/genetics , Prevalence , Risk Factors , Time Factors , Ventricular Fibrillation/diagnosis , Ventricular Fibrillation/genetics , Young AdultABSTRACT
To prevent side branch occlusion during bifurcational lesion stenting, the placement of a wire in both the main branch and side branch is performed for "side-branch protection". However, this procedure does not always prevent side branch occlusion. A procedure for placing two wires in the side branch, called "two-wire protection of side branches", is considered to be more likely to prevent occlusion compared with one-wire protection of the side branch. We report on three cases in which "two-wire protection of side branches" was effectively performed during the stenting of bifurcational lesions.
ABSTRACT
INTRODUCTION: There is increasing evidence to support a link between inflammation and atrial fibrillation (AF). However, the role of inflammation on new-onset AF is still to be elucidated. METHODS: Rats underwent induction of experimental autoimmune myocarditis (EAM). Atrial structural change was evaluated by echocardiography and histological analysis. Electrophysiological data and the in vivo atrial response to burst atrial pacing were evaluated in the acute (2 weeks after EAM induction) and chronic phases (8 weeks after induction). In addition, atrial pacing after 2, 4, and 6 h after lipopolysaccharide (LPS) infusion, when the expression of gap junctions was modified, were challenged with young healthy rats. RESULTS: AF was induced in 11 of 15 chronic phase EAM rats but not in either acute phase EAM rats or LPS infusion rats (P<.01). Echocardiography showed dilatation of both atrium and ventricle and a decrease in the ejection fraction in the chronic phase. Histology revealed severe inflammatory lesions only in the acute phase. Interstitial atrial fibrosis as well as the area of atrial myocyte increased in the chronic phase but not in the acute phase. CONCLUSIONS: AF could be induced in the chronic phase of myocarditis rats, but not in the acute phase of myocarditis rats or in rats with LPS infusion. Acute inflammation per se did not increase the occurrence of AF induction. Atrial structural remodeling caused by inflammation and hemodynamic effects is necessary to induce AF.
Subject(s)
Atrial Fibrillation/etiology , Heart Atria/pathology , Inflammation/complications , Myocarditis/complications , Animals , Atrial Fibrillation/metabolism , Atrial Fibrillation/pathology , Autoimmune Diseases/complications , Autoimmune Diseases/metabolism , Autoimmune Diseases/pathology , Blotting, Western , Chronic Disease , Connexin 43/biosynthesis , Connexins/biosynthesis , Echocardiography, Three-Dimensional , Heart Atria/metabolism , Inflammation/metabolism , Inflammation/pathology , Male , Myocarditis/metabolism , Myocarditis/pathology , Rats , Rats, Inbred Lew , Rats, Wistar , Gap Junction alpha-5 ProteinABSTRACT
The differential effects between olmesartan (OM), an angiotensin 2 type 1 receptor blocker (ARB), and azelnidipine (AZ), a calcium channel blocker (CCB), on atrial structural remodeling were studied in spontaneously hypertensive rats (SHR). Eight weeks after treatment, both OM and AZ decreased systolic blood pressure to similar levels. Histological analysis revealed that both OM and AZ had decreased the size of the atrial myocytes and interstitial fibrosis in the atrium, and that the effects of OM were greater than those of AZ. These beneficial effects of OM were associated with less atrial oxidative stress, as assessed by 3-nitrotyrosine staining, and less activation of Rac1, a regulatory component in NADPH oxidase. These results suggest that the ARB was more effective than the CCB in ameliorating atrial structural remodeling due to the suppression of oxidative stress.
Subject(s)
Angiotensin II Type 1 Receptor Blockers/pharmacology , Azetidinecarboxylic Acid/analogs & derivatives , Calcium Channel Blockers/pharmacology , Dihydropyridines/pharmacology , Heart Atria/anatomy & histology , Heart Atria/drug effects , Imidazoles/pharmacology , Tetrazoles/pharmacology , Animals , Azetidinecarboxylic Acid/pharmacology , Blood Pressure/drug effects , Heart/anatomy & histology , Heart/drug effects , Heart Atria/metabolism , Myocytes, Cardiac/cytology , Myocytes, Cardiac/drug effects , Oxidative Stress/drug effects , Rats , Rats, Inbred SHR , rac1 GTP-Binding Protein/metabolismABSTRACT
Tachycardia-induced cardiomyopathy is characterized by ventricular systolic dysfunction and congestive heart failure resulting from persistent or highly frequent tachyarrhythmias with uncontrolled heart rate. While reversible and often considered benign, few studies have examined the outcome of the disorder. The clinical characteristics, treatment, and long-term outcomes of 12 consecutive patients with tachycardia-induced cardiomyopathy (9 men, age, 51.9 +/- 17.6 years) were studied. The mean period between the occurrence of tachyarrhythmias and the development of congestive heart failure was 26.0 +/- 34.3 days. The mean heart rate on admission was 156.3 +/- 28.7 beats/min. All patients had severe heart failure with a NYHA functional class of 2.3 +/- 0.5, left ventricular ejection fraction of 0.32 +/- 0.10, and brain natriuretic peptide level of 505.7 +/- 449.1 pg/mL. In all patients, cardiac dysfunction recovered after 53.5 +/- 61.3 days. During the follow-up of 53 +/- 24 months, 2 patients had a recurrence of heart failure with uncontrolled tachyarrhythmia and 1 patient died suddenly. In tachycardia-induced cardiomyopathy, recurrent heart failure with uncontrollable tachyarrhythmia and sudden death were observed after recovery from cardiac dysfunction. A substrate for heart failure and/or life-threatening arrhythmia might persist, and careful, long-term follow-up seems required.
Subject(s)
Cardiomyopathies/etiology , Tachycardia/complications , Adult , Aged , Cardiomyopathies/physiopathology , Cardiomyopathies/therapy , Death, Sudden, Cardiac , Female , Heart Failure/etiology , Humans , Male , Middle Aged , Natriuretic Peptide, Brain/blood , Recurrence , Stroke Volume/physiology , Tachycardia/therapy , Treatment Outcome , Ventricular Dysfunction/etiologyABSTRACT
OBJECTIVE: We compared the effectiveness of sotalol on mortality and the recurrence of ventricular tachyarrhythmia (VTA) between idiopathic dilated cardiomyopathy (IDCM) and coronary artery disease (CAD). PATIENTS: Forty patients with spontaneous VTA and induced VTA associated with CAD (n = 23) and IDCM (n = 17) were studied. In all patients, sotalol was prescribed and an electrophysiologic study (EPS) was performed to evaluate its effect on the induction of VTA. There were no significant differences in left ventricular ejection fraction (LVEF) between CAD and IDCM (35%+/- 10% vs. 35%+/- 12%). RESULTS: After sotalol, there were no significant differences in the QTc interval on electrocardiogram (ECG) or in the effective refractory period in the apex of the right ventricle between the two groups, but sotalol was more effective in preventing the induction of VTA in CAD than in IDCM (65% vs. 29%; P < 0.05). During a mean follow-up period of 47 +/- 27 months, the overall VTA recurrence rate was significantly lower in CAD than in IDCM (P < 0.01). The all-cause mortality rate tended to be lower in CAD than in IDCM, but the difference was not significant (P = 0.07). Electrical storm (ES) occurred more frequently in IDCM than in CAD, (41% vs. 13%; P < 0.05), and all patients with ES (n = 10) failed to respond to sotalol as assessed by EPS. CONCLUSION: Sotalol reduced the overall VTA recurrence rate and all-cause mortality more in CAD than in IDCM.
Subject(s)
Cardiomyopathies/mortality , Cardiomyopathies/prevention & control , Myocardial Ischemia/mortality , Myocardial Ischemia/prevention & control , Sotalol/therapeutic use , Tachycardia, Ventricular/mortality , Tachycardia, Ventricular/prevention & control , Aged , Anti-Arrhythmia Agents/therapeutic use , Comorbidity , Female , Humans , Incidence , Japan/epidemiology , Male , Middle Aged , Risk Assessment/methods , Risk Factors , Secondary Prevention , Survival Analysis , Survival Rate , Treatment OutcomeABSTRACT
BACKGROUND: In both Brugada syndrome (BS) and arrhythmogenic right ventricular cardiomyopathy (ARVC), electrical abnormalities in the right ventricular outflow tract (RVOT) are important for arrhythmogenesis. OBJECTIVES: The aim of this study was to compare conduction delay in the right ventricular in BS with that in ARVC using the signal-averaged electrocardiogram. METHODS: Twenty patients with BS (18 men and 2 women; 55 +/- 12 years old; 9 symptomatic and 11 asymptomatic) and eight patients with ARVC (six men and two women; 53 +/- 16 years old) were included. We assessed the presence of late potentials (LPs) and the filtered QRS duration (fQRSd) in V(2) and V(5) using a high-pass filter of 40 Hz (fQRSd:40) and 100 Hz (fQRSd:100). RESULTS: In ARVC, there was no significant difference in fQRSd:40 between V2 and V5 (158 +/- 19 vs. 145 +/- 17 ms, respectively): however, in BS, fQRSd:40 in V2 was significantly longer than fQRSd:40 in V5 (147 +/- 15 vs. 125 +/- 10 ms, P < 0.001). In ARVC, there was no significant difference between fQRSd:40 and fQRSd:100 in V(2) and V(5) (158 +/- 19 vs. 142 +/- 23 ms and 145 +/- 17 vs. 132 +/- 9 ms, respectively). In contrast, in BS, fQRSd:100 was significantly shorter than fQRSd:40 in V2 (110 +/- 8 ms vs. 147 +/- 15, P < 0.001). The relative decrease in fQRSd:100 compared with fQRSd:40 in V2 was significantly greater in BS than in ARVC. CONCLUSION: The dominant prolongation of the fQRSd in the right precordial lead in BS was different from the characteristics of ARVC, which may be caused by the conduction delay due to fibro-fatty replacement in RV.
Subject(s)
Arrhythmogenic Right Ventricular Dysplasia/diagnosis , Brugada Syndrome/diagnosis , Electrocardiography/methods , Electrophysiologic Techniques, Cardiac/methods , Adult , Aged , Cardiovascular Physiological Phenomena , Female , Heart Ventricles/pathology , Humans , Male , Middle Aged , Signal Processing, Computer-Assisted , Ventricular Dysfunction, Right/diagnosis , Ventricular FibrillationABSTRACT
AIMS: To avoid frequent discharges of implantable cardioverter defibrillators, antiarrhythmic drugs may be needed in some patients with ventricular tachyarrhythmias. For ventricular tachyarrhythmias refractory to conventional antiarrhythmic drugs, we evaluated the efficacy of bepridil, a multiple ion-channel blocker. METHODS AND RESULTS: Sixteen patients with structural heart disease and ventricular tachyarrhythmias refractory to multiple antiarrhythmic drugs (4.1+/-1.6 drugs including class III drugs) were enrolled. Bepridil was prescribed at a mean dose of 156+/-40 mg/day. Bepridil prolonged the QT/QTc interval without affecting heart rate or the QRS duration. During a mean follow-up of 52+/-44 months, bepridil completely suppressed ventricular tachyarrhythmias in 6 of the 16 patients (38%) and the drug decreased the frequency of ventricular tachyarrhythmia recurrences by >75% in 3 of the other 10 patients. The markers of complete suppression of ventricular tachyarrhythmias during bepridil treatment included a smaller number of VT morphologies, a better NYHA functional class, and a greater drug-induced prolongation of the QT/QTc interval. The result of electrophysiologic study-guided evaluation of bepridil was closely associated with the clinical efficacy of bepridil in 7 of 8 patients. CONCLUSION: Bepridil appears to be useful to suppress drug-refractory ventricular tachyarrhythmia recurrence.
Subject(s)
Anti-Arrhythmia Agents/therapeutic use , Bepridil/therapeutic use , Tachycardia, Ventricular/prevention & control , Adult , Aged , Defibrillators, Implantable , Electrocardiography , Female , Follow-Up Studies , Humans , Male , Middle Aged , Secondary Prevention , Treatment OutcomeABSTRACT
Intracardiac electrograms are important for discrimination of tachyarrhythmia by implantable cardioverter defibrillators (ICD). A low R-wave can cause not only undersensing of ventricular tachyarrhythmia but also inappropriate discharges due to oversensing of unexpected signals because of its characteristic sensing algorithm. Therefore, this study aimed to investigate adverse events associated with R-wave amplitude. We included 115 consecutive patients followed-up over one year after implantation of a transvenous ICD system. The status of the ICD was checked every 3 months and intracardiac ventricular electrograms were analyzed. The decrease in R-wave amplitude was high in arrhythmogenic hypertrophy cardiomyopathy, arrhythmogenic right ventricular cardiomyopathy (ARVC), and sarcoidosis. Low R-waves (< 5.0 mV) were observed in 13 patients at a follow-up of 15 +/- 16 months after implantation, and the mean R-wave was 3.0 +/- 0.8 mV. The frequency of low R-waves was high in ARVC (38%), sarcoidosis (33%), and dilated cardiomyopathy (17%). All of the dilated cardiomyopathy patients with low R-waves had severe left ventricular dysfunction. Inappropriate ICD therapy resulting from T-wave oversensing occurred in 7 patients and the R-wave was < 5.0 mV in 6 of the patients. The frequency of inappropriate therapy was high in patients with sarcoidosis. In 3 patients, inappropriate therapy caused ventricular tachyarrhythmia. In conclusion, decreases in R-wave amplitude occurred in some progressive cardiac disorders and caused inappropriate ICD discharges having arrhythmogenicity. Physicians should attempt to obtain a high R-wave amplitude during ICD implantation and careful follow-up is required, especially in patients with ARVC or sarcoidosis.
Subject(s)
Defibrillators, Implantable/adverse effects , Electrocardiography , Tachycardia, Ventricular/etiology , Tachycardia, Ventricular/physiopathology , Adult , Aged , Algorithms , Analysis of Variance , Cardiomyopathy, Dilated/complications , Cardiomyopathy, Dilated/physiopathology , Cardiomyopathy, Hypertrophic/complications , Cardiomyopathy, Hypertrophic/physiopathology , Equipment Failure , Female , Follow-Up Studies , Heart Ventricles/physiopathology , Humans , Male , Middle Aged , Myocardial Ischemia/complications , Myocardial Ischemia/physiopathology , Sarcoidosis/complications , Sarcoidosis/physiopathology , Stroke Volume , Ventricular Fibrillation/complications , Ventricular Fibrillation/physiopathologyABSTRACT
Erythropoietin (EPO) has been known to have cytoprotective effects on several types of tissues, presumably through modulation of apoptosis and inflammation. The effect of EPO on myocardial inflammation, however, has not yet been clarified. We investigated the cardioprotective effects of EPO in rats with experimental autoimmune myocarditis (EAM). Seven-week-old Lewis rats immunized with cardiac myosin were treated either with EPO or vehicle and were examined on day 22. EPO attenuated the functional and histological severity of EAM along with suppression of mRNAs of tumor necrosis factor (TNF)-alpha and interleukin (IL)-6 in the hearts as well as a reduction of apoptotic cardiomyocytes. The EPO receptor (EPO-R) was upregulated in the myocardium of EAM compared with that of healthy rats. These results may suggest that EPO ameliorated the progression of EAM by modulating myocardial inflammation and apoptosis.
Subject(s)
Apoptosis/drug effects , Autoimmune Diseases/drug therapy , Autoimmune Diseases/metabolism , Cytokines/metabolism , Erythropoietin/administration & dosage , Myocarditis/drug therapy , Myocarditis/metabolism , Animals , Cardiotonic Agents/administration & dosage , Erythropoietin/genetics , Humans , Male , Myocarditis/pathology , Rats , Rats, Inbred Lew , Recombinant Proteins/administration & dosage , Treatment OutcomeABSTRACT
The beneficial effects of quinidine on ST-segment elevation, inducible ventricular tachyarrhythmias, and episodes of ventricular tachyarrhythmia have been reported in Brugada syndrome. This is the first report describing quinidine-induced elimination of the late potential, which is considered one of the parameters for an arrhythmic event, in a patient with Brugada syndrome.
Subject(s)
Anti-Arrhythmia Agents/therapeutic use , Bundle-Branch Block/therapy , Heart Rate/drug effects , Quinidine/therapeutic use , Ventricular Fibrillation/drug therapy , Bundle-Branch Block/complications , Bundle-Branch Block/diagnosis , Combined Modality Therapy , Defibrillators, Implantable , Electrocardiography , Humans , Male , Middle Aged , Signal Processing, Computer-Assisted , Ventricular Fibrillation/complications , Ventricular Fibrillation/surgeryABSTRACT
Clinical implication of mechanical alternans is yet unclear. It may suggest the risk for sudden death in patients with chronic heart failure. Two cases with dilated cardiomyopathy showed mechanical alternans during diagnostic cardiac catheterization. They suddenly died due to ventricular fibrillation before the induction of beta-blocker therapy. Patients with mechanical alternans should be treated under intense monitoring until the induction of beta-blocker therapy.
Subject(s)
Cardiomyopathy, Dilated/complications , Cardiomyopathy, Dilated/physiopathology , Heart Conduction System/physiopathology , Ventricular Fibrillation/etiology , Ventricular Fibrillation/physiopathology , Adult , Cardiac Catheterization , Cardiomyopathy, Dilated/diagnosis , Electrocardiography , Fatal Outcome , Humans , Male , Middle Aged , Risk Assessment , Ventricular Fibrillation/diagnosisABSTRACT
We report a case of Graves' disease in a patient on regular hemodialysis. The patient also suffered from Wolff-Parkinson-White (WPW) syndrome and paroxysmal atrial fibrillation, which may both have been manifestations of the Graves' disease because of the increased oxygen demand. To our knowledge, this is the first case to illustrate the usefulness of the antithyroid agent propylthiouracil for Graves' disease complicated by endstage renal disease (ESRD) and WPW syndrome.